insights_auto
Why is CGEM down 22.15%?
Dive Deeperchevron_right
CGEM:NASDAQ
Cullinan Therapeutics Inc
$16.87
arrow_downward
-22.15%(-4.80) 1D
$16.88
arrow_upward
+0.04% (+0.0062)todayPre-market
Closed: Sep 23, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CGEM...
Open
$21.67
High
$21.67
Low
$16.78
Mkt. cap
1.09B
Avg. vol.
891.84K
Volume
886.00
52-wk high
$23.19
52-wk low
$5.68
EPS
-$3.41
Beta
0.01
Shares outstanding
64.36M
No. of employees
109
Open
$21.67
High
$21.67
Low
$16.78
Mkt. cap
1.09B
Avg. vol.
891.84K
Volume
886.00
52-wk high
$23.19
52-wk low
$5.68
EPS
-$3.41
Beta
0.01
Shares outstanding
64.36M
No. of employees
109
News stories
From web sources and news partners
Trefis
·
3 hours ago
Market Movers | Winners: QNC, EGHT, FSLY | Losers: CGEM, ALKT, RAPP
Investor's Business Daily
·
14 hours ago
Biotech Stocks Widely Dive. Here Are The Hardest Hit.
Quiver Quantitative
·
15 hours ago
$CGEM stock is down 20% today. Here's what we see in our data.
Simply Wall Street
·
1 day ago
Cullinan Therapeutics (CGEM) Could Be 35% Undervalued As Phase 3 Lung Cancer Data Lands
About Cullinan Therapeutics Inc